Second Pharma Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VALSARTAN, with a corresponding US DMF Number 25848.
Remarkably, this DMF maintains an Active status since its submission on March 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 05, 2017, and payment made on June 16, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II